Internal Funding Opportunities
Pathway Grant - Deadline for abstracts: August 19, 2021
To address the gap between the Temerty Faculty of Medicine’s Project Grant proposals and CIHR’s limited available funding envelope, the OVDRI has launched a Pathway Grant for the Fall 2021 Project Grant competition. This funding program functions as an internal CIHR bridge grant for top-rated Project Grant proposals from on-campus Temerty Faculty of Medicine applicants: Up to 6 grants per Project competition (Spring and Fall) $50,000 for 1 year, w/potential 1-year no-cost extension Top 6 unfunded proposals, by percentile rank within review committee, will receive Pathway Grants Terms & Conditions: To be eligible for a Pathway Grant – you must be enrolled and in good standing with the Temerty Faculty of Medicine's College of Internal Scientific Reviewers at the time of the prior Project Grant competition. To be in good standing, you simply have to remain available to serve as an internal reviewer should you be selected to do so by the College for a specific grant. Expense eligibility follows the Tri-Agency Guide on Financial Administration
EMHSeed Funding - Deadline for submission: TBD
Information on the Spring 2022 call for applications is forthcoming
Expanding research impact through inter-disciplinary collaboration
The Joint EMHSeed and XSeed is an interdivisional research funding program designed to promote multi-disciplinary research and catalyze new innovative partnerships between a coPI from the Faculty of Applied Science and Engineering (FASE) and a coPI from outside Engineering. Partner divisions for these programs are:
For EMHSeed: Faculty of Medicine (FoM), UofT Affiliated Hospitals, Medicine by Design (MbD), Translational Biology and Engineering Program (TBEP)
For XSeed: Faculty of Arts and Science (FAS), University of Toronto Mississauga (UTM), University of Toronto Scarborough (UTSC), Dalla Lana School of Public Health (DLSPH), as well as other UofT Divisions.
Funding is available for a maximum of fifteen (15) new collaborative projects beginning in early September 2020.
The budget for each Seed project will be $60,000 CAD/year for two (2) years. In exceptional cases, a no-cost extension for an additional year will be considered. The $60,000 CAD/year amount for each project is the sum of total cash invested by each of the participating Faculties and departments/institutes,
Each coPI should be eligible to hold, as PI, tri-council agency grants (NSERC, CIHR, or SSHRC).
One PI should have a primary appointment with an Engineering unit, and one PI should have his/her primary appointment outside Engineering.
A PI can hold a maximum of one EMHSeed and one XSeed funded project at any point in time.
EMHSeed funding is for faculty members that have an appointment status at FoM and UofT Affliated Hospitals; XSeed is for faculty members with appointment status at FAS, UTM, UTSC, DLSPH and other divisions.
Deadline for documentation: March 31, 2021 at 12:00 noon.
McLaughlin Centre 2022 Accelerator Grants - Deadline for LOIs: TBD
Information on the Winter 2022 competition is forthcoming.
LOI Deadline: December 4, 2020
LOI Decision: January 8, 2021
Application Deadline: March 5, 2021
Application Decision: April 23, 2021
Funding Start: May 1st, 2021 *LOI form at: www.mclaughlin.utoronto.ca
The McLaughlin Centre is pleased to announce its 11th research funding competition. The competition will be based on invited grant applications passing an initial letter of intent stage. Both steps will go through committee peer-review adjudicated by the Director. Letters of Intent up to two pages long should outline (i) background and rationale, (ii) objectives and activities, (iii) relevance to the McLaughlin Centre mission, (iv) planned deliverables and (v) a brief budget summary. Full grant applications will be a maximum of 10 pagesincluding references. Priority will be given to applications demonstrating promise for near-term deliverables, potential to seed larger grants, and those involving two or more institutions from the University of Toronto Faculties (and their Departments and Institutes) and the hospitals/research institutes fully affiliated with the University of Toronto (TAHSN). Successful grants will be awarded for one year with up to $100,000 from the McLaughlin Centre. A requirement is that the McLaughlin Centre investment be equally leveraged with other funds necessary for the completion of the project. (Note: considering other funding opportunities in Toronto, if your project involves cancer or COVID-19 please contact us in advance. We also prefer one application per Principal Investigator). The emphasis in this Call will be Genomic Data Generation and Integration for Discovery: 1. Building clinical and control genome-wide datasets. The emphasis this year will be projects for long-read genome sequencing, RNAseq, and epigenomics datasets for discovery and, 2. Importing genomic data from other databases (e.g. UK Biobank) and integrating/analyzing with local data, as well as linking whole genome datasets with health and administrative databases. Developing integrated analysis pipelines and databases for discovery will also be considered.
MITO2i - Graduate Student Scholarships and Fellowship in Partnership with the TDRA - Deadline for submission: September 30, 2021
MITO2i is pleased to announce its 2021 Funding Competition for Graduate Student Scholarships and Fellowship in partnership with the Toronto Dementia Research Alliance (TDRA).
Graduate Student Scholarships
Aimed at training the next generation to maintain cross-cutting research, build momentum, and generate strong, sustainable research capacity in Canada for mitochondrial medicine. The Graduate Student Scholarship Awards will provide funding support to highly accomplished graduate student candidates who demonstrate outstanding potential to become independent researchers in Mitochondrial Research and Medicine.
The Scholarship is open to all graduate students at the University of Toronto and participating hospital partners (see eligibility requirements for more details).
Research areas can include but not limited:
- research in all disease and clinical applications in which mitochondrial mutations, defects and/or dysfunction may play a role in the pathogenesis of disease
- research using mitochondrial related data sets for AI and machine learning
- mitochondrial genetics and genomics
- development of novel compounds that improve mitochondrial function and therapeutic treatments such as mitochondrial transplant, mitochondrial augmentation therapy, precision nutrition and others
- development of diagnostic tools and technologies for detection of mitochondria defects
- projects concerning the law, ethics, patient counselling, health policy and economics and epidemiology of mitochondrial medicine research.
Submission deadline: Thursday September 30th, 2021 5pm EST to firstname.lastname@example.org
The Mitochondria Innovation Initiative (MITO2i) and the Toronto Dementia Research Alliance (TDRA) have partnered to co-fund an innovative new fellowship to support research that explores the role of the mitochondria in dementia. Fellows will be engaged in collaborative, multi-disciplinary research that aligns with the goals of MITO2i and the TDRA, to understand the role of mitochondria in complex brain diseases and to advance the path to a cure for dementia, respectively.
This MITO2i/TDRA fellowship is open to MD specialists or PhDs pursuing post-doctoral fellowships. Fellows will lead a research project that focuses on mitochondrial function or dysfunction in relation to dementia.
Key areas of focus include biomarkers of mitochondrial dysfunction, and the impact of these disorders on cognitive and functional abilities, quality of life, interpersonal relationships, and other biological correlates.
For full details of the call, eligibility requirements and submission instructions please click the link below:
Submission Deadline: Thursday September 30th, 2021 5pm EST to info@mito2i
Drucker Family Innovation Fund Grants 2022/2023 - Deadline for submissions: September 14, 2021
This Drucker Family Innovation Fund Grants is a joint funding program between the Banting & Best Diabetes Centre (BBDC) and the University Health Network/Mount Sinai Hospital Department of Medicine. Multiple grants will be awarded per year. The number of awards depends on the total interest earned on these endowed funds.
The program provides funding of up to $50,000 per application to enable eligible investigators to explore innovative research that may change the paradigm and reorient the field in a new direction. The emphasis of this grant is on INNOVATION. Applicants must demonstrate to reviewers that their proposal does not simply represent a logical extension of their existing research program.
This funding is not to be used as bridging or emergency funding, nor is it intended as funding for ongoing studies.
Preference will be given to high risk innovative proposals focused on diabetes and metabolism research; however, in the absence of meritorious applications in the area of diabetes and metabolism, submissions related to other areas of biomedical research will be considered. (This program is not intended to support activities in care delivery, evaluation of education programs, or practical issues in clinical management)
The application must include an explanation as to how this project constitutes a highly innovative potentially paradigm-shifting undertaking for the applicant(s) and is not just an extension of, or related to, ongoing research efforts.
Preference will be given to applications that represent a completely new initiative in biomedical research/basic sciences for a particular investigator(s). The most innovative and potentially transformative ideas will receive funding preference.
The principal applicant must hold a faculty appointment with the University of Toronto at the level of Assistant, Associate, or Full Professor at the time of application submission.
The principal applicant must be appointed to the University of Toronto or a University of Toronto-affiliated institution. In addition to the above, the principal applicant must be either:
A registered member* of the Banting & Best Diabetes Centre at the time of application submission. (*for information about BBDC membership please view the Membership section of this website), or
A faculty member in the Department of Medicine who holds their primary hospital appointment at Mount Sinai Hospital or the University Health Network
Co-applicants must be independent researchers (not trainees or research associates). Co-applicants are not required to be members of the BBDC, UHN/MSH Department of Medicine faculty, or U of T faculty.
The proposed research must be conducted at the University of Toronto or one of its affiliated institutions.
Faculty can only submit one application as the principal applicant.
Up to $50,000 will be awarded to successful applicants.
One-year funding period commencing on July 1, 2022. All grant recipients must be prepared to begin the research on July 1, 2022.
Submit a completed application to the Banting & Best Diabetes Centre by the deadline date. See the application form for complete instructions.
Download the 2022/2023 Drucker Family Innovation Fund Grant application form (PDF)
Applications must be received by 4 p.m., September 14, 2021. Late or incomplete applications will not be considered.
Ukraine-Toronto Education and Collaboration Initiative - Deadline for applications: September 30, 2021
The Temerty Faculty of Medicine has launched a Ukraine-Toronto Education and Collaboration Initiative, generously supported by the Temerty Foundation’s landmark gift. A new fund has been established to support education and research, with the goal of increasing and deepening our collaborations and partnerships with clinicians, health educators and researchers in Ukraine.
Grants are available with the goal of supporting emerging health leaders in Ukraine and the University of Toronto’s Temerty Faculty of Medicine in Canada through collaborative research and educational programs and activities.
Examples of initiatives may include, but are not limited to:
- Collaborative research or educational projects that are co-led by researchers at Temerty Medicine and in Ukraine
- Capacity building trips to Ukraine led by Temerity Medicine faculty member(s)
- Support for Temerty Medicine learners (medical students, clinical trainees, residents, fellows, graduate students) working on projects with demonstrated potential for impact in Ukraine
- Steps to build a network of colleagues interested in a sustained relationship with Ukraine
Please see the application form for further details.
Maximum Grant: $75,000 CDN (to support up to 2 years maximum)
Applications to be submitted as one PDF package by 11:59pm on September 30, 2021 to email@example.com. Late applications will not be considered and the committee will only review one application per person.The outcome of the competition will be announced by December 2021 and successful applicants will be notified directly.
Banting & Best Diabetes Centre: Novo Nordisk-BBDC Pilot and Feasibility Grants 2022/2023. Deadline for submissions: November 18, 2021.
This program provides funding of up to $40,000 per application to enable eligible investigators to explore new diabetes research initiatives in the area of biomedical research/basic sciences. Three to four awards are available for this competition. This funding is not to be used as bridging or emergency funding, nor is it intended as funding for ongoing studies. To be eligible to apply, the principal applicant must hold a faculty appointment with the University of Toronto at the level of associate, assistant, or full professor at the time of application submission. Those who received a 2021/2022 Pilot and Feasibility Grant from the BBDC as principal applicant are not eligible to apply for this competition as a principal or co-applicant. Deadline for applications: November 18, 2021 at 4pm.